HB 383 requires Tennessee's health commissioner to add alpha-gal syndrome - a rare meat allergy triggered by tick bites - to the state's official list of reportable diseases by July 1, 2025. Healthcare providers must then report diagnosed cases to the Department of Health under existing rules. This bill directly affects medical professionals who will need to submit these reports and public health officials who will track the condition. The law amends Tennessee Code Titles 4, 63, and 68 to implement this change, effective March 26, 2025.
SB 282, the "Individualized Investigational Treatment Act," creates a legal framework for patients with life-threatening or severely debilitating illnesses to access personalized medical treatments (like gene therapies or vaccines tailored to their genetic profile) when standard FDA-approved options have been exhausted. It directly affects eligible patients (who must meet specific criteria including physician attestation and written informed consent) and eligible facilities (those complying with federal human subjects protections). Key provisions require detailed written consent covering all treatment options, risks, and financial liability, while clarifying that insurers, health plans, and providers are **not obligated** to cover these treatments or related costs (TCA §§ 63-6-1304(a)-(d)). The law takes effect July 1, 2025, and explicitly states that heirs cannot be held liable for unpaid treatment debts if a patient dies during treatment (TCA § 63-6-1305).
This bill adds hepatitis C antibody (anti-HCV) testing to the standard blood screening required for all pregnant women in Tennessee during initial prenatal visits and between weeks 28-32 of pregnancy. If the anti-HCV test is reactive, labs must automatically conduct a follow-up HCV RNA test without requiring additional orders. It directly affects all pregnant women receiving routine prenatal care in Tennessee, expanding the required screening panel to include hepatitis C alongside existing tests for syphilis, rubella, and hepatitis B. The changes take effect July 1, 2025, and align hepatitis C testing protocols with existing disease reporting requirements for maternal health.
HB 404 extends the professional music therapy advisory committee under Tennessee's psychology board until June 30, 2027. This bill updates Tennessee Code Sections 4-29-246 and 4-29-248 to formally maintain the committee's existence, preventing its automatic termination. The committee, which advises the Board of Examiners in Psychology on music therapy licensure, is directly affected by this extension. The change ensures continuity for this advisory body without altering any substantive licensing rules.
HB 15 would allow Tennessee's governor to expand Medicaid eligibility exclusively for sickle cell disease treatment, in alignment with federal law. The bill requires the governor to negotiate with federal health officials (Centers for Medicare and Medicaid Services) on the specific terms of this expansion. This change would directly affect Tennessee residents diagnosed with sickle cell disease by potentially providing Medicaid coverage for their treatment. The expansion is strictly limited to sickle cell disease and must comply with the federal Patient Protection and Affordable Care Act.
HB 1236, the "Tennessee Health SNAP Act," would require Tennessee's Department of Human Resources to seek a federal waiver from the USDA to prohibit SNAP (food stamp) benefits from being used to purchase candy and soft drinks. If approved, this restriction would directly affect SNAP recipients in Tennessee who currently use benefits for these items. The bill mandates that the waiver request include public health justification, a plan for retailer system updates, recipient education on healthy alternatives, and a tracking system for spending and health data. It also requires annual reports to state leaders on the waiver status and impact. The bill is pending Senate action and would take effect July 1, 2025, if enacted.
HB 18 proposes a temporary health coverage program for Tennesseans who don't qualify for existing TennCare or CoverKids. It would provide up to 60 months of medical assistance (resetting at age 21) to individuals under 21 with income ≤138% of the federal poverty level, or adults ≥21 with similar income, subject to strict 12-month/24-month usage limits. The program requires a federal waiver by December 2025, uses 90% federal/10% state funding, and explicitly states it does not replace eligibility for regular programs (benefits pause if enrollment becomes possible). The bill failed in the Insurance Committee on March 5, 2025, and remains inactive.
SB 610 requires TennCare to cover continuous glucose monitors (CGMs) for eligible members with specific diabetes conditions. It directly affects TennCare enrollees diagnosed with Type 1 diabetes, gestational diabetes, or Type 2 diabetes meeting documented criteria like frequent low blood sugar episodes, high A1C levels, or hospitalizations related to diabetes complications. The bill mandates coverage only when prescribed by an endocrinologist or diabetes specialist confirming the member meets the eligibility requirements. The law takes effect January 1, 2026.
